Xlife Sciences AG (SWX:XLS)
Switzerland
· Delayed Price · Currency is CHF 22.10
-0.40 (-1.78%)
At close: Mar 6, 2026
Xlife Sciences AG Market Cap
Xlife Sciences AG has a market cap or net worth of 127.46 million as of March 6, 2026. Its market cap has increased by 5.71% in one year.
Market Cap
127.46M
Enterprise Value
274.97M
Revenue
839.38K
Ranking
n/a
PE Ratio
4.86
Stock Price
22.10
Market Cap Chart
Since February 10, 2022, Xlife Sciences AG's market cap has decreased from 240.46M to 127.46M, a decrease of -46.99%. That is a compound annual growth rate of -14.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 127.46M | -10.53% |
| Dec 30, 2025 | 142.46M | -2.32% |
| Dec 30, 2024 | 145.84M | -47.72% |
| Dec 29, 2023 | 278.96M | 77.76% |
| Dec 30, 2022 | 156.93M | -34.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Molecular Partners AG | 147.73M |
| BioVersys AG | 149.71M |
| Santhera Pharmaceuticals Holding AG | 226.17M |
| Newron Pharmaceuticals | 379.89M |
| Basilea Pharmaceutica AG | 645.31M |
| Idorsia | 920.51M |
| EvoNext Holdings | 6.66M |
| Addex Therapeutics | 5.36M |